一种相分离粒子滤出法制备组织、 器官修复用多孔支架的方法 技术领域 Method for preparing porous scaffold for tissue and organ repair by phase separation particle filtration method TECHNICAL FIELD
本发明属于生物医学工程领域, 涉及一种组织、 器官修复用多 孔支架的制备方法, 特別涉及到一种作为细胞生长载体用的生物可 降解多孔支架的制备方法。 背景技术 The invention belongs to the field of biomedical engineering, and relates to a method for preparing a multi-hole scaffold for tissue and organ repair, in particular to a method for preparing a biodegradable porous scaffold as a cell growth carrier. Background technique
近年来, 組织、 器官的缺损或功能衰竭给人类健康带来了巨大 威胁, 使无数家庭承受了破坏性的打击。 临床上器官、 组织衰竭缺 损的频繁发生和可供移植器官、 组织的严重不足之间的矛盾, 日益 成为人民健康水平提高的瓶颈。 为了緩解上述矛盾, 组织工程通过 多孔支架, 用本体细胞在体外培养了各种可植入体内的组织及器官。 组织工程用多孔支架应符合以下要求: 1 )表面能使细胞粘附并生长; 2) 植入体内后, 聚合物及其降解产物不会引起炎症及毒副作用 ; 3) 多孔支架应具有成三维结构; 4) 为提供细胞外再生的足够空间, 多 孔支架孔隙率不得低于 90% ; 5) 在完成組织再生后聚合物能立即被 机体吸收; 6) 多孔支架的降解速率应在与不同組织细胞繁殖速度相 匹配。 In recent years, tissue or organ defects or functional failures have posed great threats to human health and caused countless families a devastating blow. In clinical practice, the contradiction between the frequent occurrence of organ and tissue failure and the serious shortage of organs and tissues available for transplantation has increasingly become a bottleneck for improving people's health. In order to alleviate the above-mentioned contradiction, tissue engineering adopted a porous scaffold to culture a variety of implantable tissues and organs in vitro using bulk cells. The porous scaffold for tissue engineering should meet the following requirements: 1) the surface can make cells adhere and grow; 2) the polymer and its degradation products will not cause inflammation and toxic side effects after being implanted in the body; 3) the porous scaffold should have a three-dimensional structure Structure; 4) To provide sufficient space for extracellular regeneration, the porosity of the porous scaffold must not be less than 90%; 5) The polymer can be absorbed by the body immediately after the tissue regeneration is completed; 6) The degradation rate of the porous scaffold should be different from that of different tissues The rate of cell proliferation matches.
国外已对組织工程所用支架的制备方法已有广泛的研究。 到目 前为止, 可基本把制备方法分为 : 1、 非编织的纤维法, 该法的优点 是孔隙率较高, 但植入体内后, 难以保持预定的形状; 2、溶液浇铸、 成孔剂滤出法, 该法所用的成孔剂含量低, 由于采用溶液浇铸于器 中, 从而导致成孔剂下沉, 孔隙分布不均匀以及上下表面形态出 现差异; 3、 三维层化法, 通过制备多孔膜, 然后再通过溶剂把各层 粘接起来, 从而形成三维的支架, 该法工艺复杂, 而且在粘接过程 中, 粘接部分孔被封闭, 从而形成界面, 使材料内部形态不均匀 ; 4、 確認用写 L
熔融加工法, 该法在聚合物的熔点以上, 把成孔剂与聚合物共混挤 入模具, 冷却得到预定形状的多孔支架, 该法的缺点是在挤出机里, 由于熔体与成孔剂的密度相差较大, 因而混合难以均匀, 而且部分 聚合物, 尤其是生物可降解的聚合物在熔融加工时, 容易热降解; 5、 相分离法, 该法采用溶液混合物冷却到溶剂的熔点以下, 从而产生 相分离, 再通过真空干燥, 从而得到多孔支架, 该法的缺点是所得 的孔径一般在 100微米以下, 而且控制较为困难; 6、 高压二氧化碳 法, 该法采用把已成型的聚合物暴露于高压二氧化碳, 再通过減压 把溶于聚合物中的二氧化碳释放出来, 从而形成多孔支架, 该法的 缺点是所形成的孔是封闭的。 Extensive research on the preparation methods of scaffolds used in tissue engineering has been conducted abroad. So far, the preparation methods can be basically divided into: 1. Non-woven fiber method, which has the advantage of high porosity, but it is difficult to maintain the predetermined shape after implantation in the body; 2. Solution casting, porogen Filtration method, the content of pore-forming agent used in this method is low, because the solution is cast into the device, which causes the pore-forming agent to sink, the pores are unevenly distributed, and the upper and lower surface morphologies are different; 3. The three-dimensional layering method The porous membrane is then bonded to each other by a solvent to form a three-dimensional scaffold. The method is complicated, and during the bonding process, the holes of the bonding part are closed, thereby forming an interface and making the internal shape of the material uneven. 4. Make sure to write L The melt processing method is a method in which a pore former and a polymer are blended and extruded above a melting point of a polymer into a mold, and cooled to obtain a porous stent of a predetermined shape. The disadvantage of this method is that in the extruder, the melt The porosity has a large difference in density, so it is difficult to mix uniformly, and some polymers, especially biodegradable polymers, are easily thermally degraded during melt processing; 5. Phase separation method, which uses a solution mixture to cool to a solvent. Below the melting point, phase separation occurs, and the porous scaffold is obtained by vacuum drying. The disadvantage of this method is that the obtained pore diameter is generally below 100 microns, and it is difficult to control. 6. The high-pressure carbon dioxide method, which uses the formed The polymer is exposed to high-pressure carbon dioxide, and the carbon dioxide dissolved in the polymer is released under reduced pressure to form a porous scaffold. The disadvantage of this method is that the pores formed are closed.
国内尚未见有组织工程用多孔支架制备新方法的报道。 已有的 方法也为直接从国外照搬过来。 发明的公开 No new method for preparing porous scaffolds for tissue engineering has been reported in China. The existing methods are also copied directly from abroad. Disclosure of invention
本发明的目的在于提供一种以相分离粒子滤出法制备組织、 器 官用修复多孔支架的方法, 该方法吸取了溶液浇铸粒子滤出法、 相 分离法的优点, 解决了单纯相分离法孔径太小的问题,及溶液浇铸粒 子滤出法制备三维材料的粒子沉降问题。 An object of the present invention is to provide a method for preparing a porous repair scaffold for tissues and organs by a phase separation particle filtration method. The method absorbs the advantages of the solution casting particle filtration method and the phase separation method, and solves the pore diameter of the simple phase separation method. The problem is too small, and the problem of particle settling of three-dimensional materials prepared by solution casting particle filtration method.
为达到上述目的,本发明采取的技术方案如下: To achieve the above objective, the technical solution adopted by the present invention is as follows:
1、 通过标准筛筛得粒径在 50徵米〜 500微米范围内的成孔剂, 该成孔剂为氯化钠、 氯化钾、 醋酸钾、 碳酸氢钠、 碳酸钠、 柠檬酸、 柠檬酸钾等。 1. Pass a standard sieve to obtain a pore-forming agent with a particle size in the range of 50 to 500 microns. The pore-forming agent is sodium chloride, potassium chloride, potassium acetate, sodium bicarbonate, sodium carbonate, citric acid, and lemon. Potassium acid, etc.
2、 将选自聚 3-羟基丁酸酯 (PHB) 、 3-羟基丁酸和 3-羟基己酸 的共聚物(PHB- HH)、聚乳酸(PLA)、乳酸和羟基乙酸的共聚物(PLGA) 、 3 -羟基丁酸和 3-羟基戊酸的共聚物、 聚羟基乙酸等生物可降解聚合 物中的一种或几种溶于氯仿、 1,4-二氧环六烷、 1,2-二氯乙烷、 1,4- 二氧六环 -水混合物、 吡啶等溶剂中的一种中, 得到浓度为 5¾〜30
(聚合物质量与溶剂体积之比) 的溶液。 2. A polymer selected from the group consisting of poly (3-hydroxybutyrate (PHB), 3-hydroxybutyric acid and 3-hydroxyhexanoic acid (PHB-HH), polylactic acid (PLA), copolymer of lactic acid and glycolic acid ( PLGA), a copolymer of 3-hydroxybutyric acid and 3-hydroxyvaleric acid, and one or more of biodegradable polymers such as polyglycolic acid are soluble in chloroform, 1,4-dioxane, 1, In a solvent such as 2-dichloroethane, 1,4-dioxane-water mixture, and pyridine, the concentration is 5¾ ~ 30 (The ratio of polymer mass to solvent volume).
3、 按 1 : 10-1: 40的比例 (聚合物与成孔剂的质量比) (具体 数与溶液浓度项匹配) 把步骤 1 中的成孔剂加入到步骤 2所述的溶 液中, 搅拌均匀 。 3. According to the ratio of 1: 10-1: 40 (mass ratio of polymer to pore-forming agent) (the specific number matches the solution concentration term), add the pore-forming agent in step 1 to the solution described in step 2, Stir well.
4、 在搅拌下,将步骤 3 中的混合物倒入预设温度的模具中骤冷, 骤冷温度在 -180°C~11.8°C之间,使制品完全冻住; 4. With stirring, pour the mixture in step 3 into a mold with a preset temperature and quench it. The quenching temperature is between -180 ° C ~ 11.8 ° C, so that the product is completely frozen;
5、开模,把已成型的制品冷冻干燥,冷冻温度在 -180°C~11.8°C之 间, 千燥压力在 0.001325MPa~0MPa, 冷冻干燥时间 2~4天。 5. Open the mold and freeze-dry the formed product. The freezing temperature is between -180 ° C ~ 11.8 ° C, the dry pressure is between 0.001325MPa ~ 0MPa, and the freeze-drying time is 2 ~ 4 days.
6、 将 5 中冷冻干燥过的制品浸泡入去离子水或弱酸中,或先浸 入弱酸性水溶液中, 然后再将制品取出放入去离子水中浸泡, 去离 子水或弱酸性溶液的浸泡时间分别为 70~80小时。 6. Soak the freeze-dried products in 5 into deionized water or weak acid, or immerse them in a weakly acidic aqueous solution, and then take out the products and soak them in deionized water. The soaking times of the deionized water or weak acid solution are respectively It is 70 ~ 80 hours.
7、 再次对制品进行干燥, 使全部溶剂挥发。 7. Dry the product again to allow all solvents to evaporate.
在本发明所述的制备方法中, 所述可生物降解聚合物的浓度随 着所选择的成孔剂的种类和被修复组织对孔隙大小的要求而变化, 优选为 6~15%; In the preparation method of the present invention, the concentration of the biodegradable polymer varies with the type of pore-forming agent selected and the requirement of the pore size of the repaired tissue, and is preferably 6-15%;
在本发明所述的制备方法中, 所述聚合物与成孔剂的质量比的 选择应使得所得到的均匀混合物中的成孔剂不发生沉淀和常规流 动, 其根据被修复组织对不同细胞的要求而变化,优选为 1:15〜1:35; 在本发明所述的制备方法中, 所述步骤 4中的骤冷溫度为 -170°C~0°C, 骤冷时间为 5分钟〜 2小时; In the preparation method of the present invention, the mass ratio of the polymer to the pore-forming agent is selected so that the pore-forming agent in the obtained homogeneous mixture does not undergo precipitation and regular flow. The requirements vary, preferably 1: 15 ~ 1: 35; In the preparation method of the present invention, the quenching temperature in the step 4 is -170 ° C ~ 0 ° C, and the quenching time is 5 minutes. ~ 2 hours;
在本发明所述的制备方法中, 所述步骤 5 中制品冷冻千燥的冷 冻温度为- 170°C~0°C; In the preparation method of the present invention, the freezing temperature of the product in step 5 is -170 ° C ~ 0 ° C;
在本发明所述的制备方法中, 所述步骤 6 中的弱酸性水溶液盐 酸水溶液, 弱酸溶液的 H+浓度在 2Μ~1(Γ4Μ之间 。 In the method according to the present invention, a weakly acidic aqueous solution of hydrochloric acid in the step 6, the weak acid solution in a concentration of H + 2Μ ~ 1 (between Γ 4 Μ.
在本发明所述的制备方法中, 所述步骤 6 中制品与去离子水或 弱酸性水溶液的体积比在 1: 50〜1: 200之间, 每 5〜8小时更换一次 去离子水或酸性水溶液。
在本发明所述的制备方法中, 所述步骤 7 对制品的再次干燥是 在真空干燥箱中进 t的, 温度为 37 °C, 压力为 0.001325MPa~OMPa , 千燥 24-48小时之间 。 In the preparation method of the present invention, the volume ratio of the product to deionized water or weakly acidic aqueous solution in step 6 is between 1: 50 ~ 1: 200, and the deionized water or acidity is replaced every 5 ~ 8 hours. Aqueous solution. In the preparation method of the present invention, the re-drying of the product in step 7 is carried out in a vacuum drying box, the temperature is 37 ° C, the pressure is 0.001325MPa ~ OMPa, and it is dried for 24 to 48 hours. .
应用本发明的方法制备的组织、 器官修复用支架材料,具有下述 特点和优点: The scaffold material for tissue and organ repair prepared by applying the method of the present invention has the following characteristics and advantages:
( 1 ) 孔隙率可达 90%以上。 (1) The porosity can reach more than 90%.
( 2) 所得到的支架材料生物相容性好, 且生物可降解。 (2) The obtained scaffold material has good biocompatibility and is biodegradable.
( 3 ) 直接制备三维立体结抅的支架材料, 解决了溶液浇铸粒子 滤出法的粒子沉降问题。 (3) Directly preparing a three-dimensional scaffolding scaffold material, which solves the problem of particle sedimentation by solution casting particle filtration method.
( 4) 孔的大小范围在几徵米到 300微米之间, 即有大孔, 又有 小孔, 解决了单纯相分离法孔径太小的问题。 并且大孔-大孔、 大孔 -小孔、 小孔 -小孔之间相互连通 (如图 1、 如图 2所示), 适合各种 大小细胞的生长, 避免了高压二氧化碳法的闭孔问题。 (4) The size of the pores ranges from a few tens of meters to 300 microns, that is, there are large pores and small pores, which solves the problem that the pore size of the simple phase separation method is too small. In addition, the macropore-macropore, macropore-smallpore, and micropore-smallpore are connected to each other (as shown in Fig. 1 and Fig. 2), which is suitable for the growth of cells of various sizes and avoids the closed pores of the high pressure carbon dioxide method problem.
( 5) 不须高温操作, 避免了熔融加工法中可能造成的聚合物降 解问题。 附图的筒要说明 (5) High temperature operation is not required to avoid polymer degradation problems caused by melt processing. The tube of the drawings is to be explained
图 1为本发明方法制备的聚 3-羟基丁酸酯支架材料放大倍数 10 万倍的扫描电镜图 ; FIG. 1 is a scanning electron microscope image of a poly 3-hydroxybutyrate scaffold material prepared by the method of the present invention at a magnification of 100,000 times;
图 2为本发明方法制备的聚 3-羟基丁酸酯支架材料放大倍数为 1 1万倍扫描电镜图 ; FIG. 2 is a scanning electron microscope image of a poly 3-hydroxybutyrate scaffold prepared by the method of the present invention at a magnification of 11 thousand times; FIG.
图 3为本发明方法制备的聚 3-羟基丁酸酯支架材料的外观图; 图 4为本发明方法制备的 3-羟基丁酸与 3 -羟基己酸共聚物的支 架材料为基础得到的外观形状复杂的耳形支架的外观图 。 实现本发明的最佳方式 FIG. 3 is an external view of a poly 3-hydroxybutyrate stent material prepared by the method of the present invention; FIG. 4 is an appearance obtained based on a stent material of a copolymer of 3-hydroxybutyric acid and 3-hydroxyhexanoic acid prepared by the method of the present invention; Appearance of complex ear-shaped bracket. The best way to implement the invention
实施例 1
1、在 55°C下, 于烧杯中用 1 克聚(3-羟基丁酸酯) (PHB), 10ml 1 , 4-二氧六环配制成 10% (质量比体积) 的 PHB溶液。 Example 1 1. Prepare a 10% (mass to volume) PHB solution in a beaker with 1 g of poly (3-hydroxybutyrate) (PHB), 10 ml of 1, 4 -dioxane at 55 ° C.
2、 加入 15g的 NaCl, 其中 NaCl直径在 100微米〜 400微米之间。 2. Add 15g of NaCl, where the diameter of NaCl is between 100 microns and 400 microns.
3、 搅拌下于- 10°C下骤冷。 3. Stir at -10 ° C while stirring.
4、 冷冻 10分钟后, 切取所需形状的样品。 4. After freezing for 10 minutes, cut a sample of the desired shape.
5、 于- 10°C、 于 0.001325MPa〜0MPa下冷冻干燥 4天。 5. Freeze-dry at -10 ° C for 4 days at 0.001325MPa ~ 0MPa.
6、 取出制品, 将其浸入去离子水, 每 8小时换一次水, 浸泡 3 天。 6. Take out the product, immerse it in deionized water, change the water every 8 hours, and soak for 3 days.
7、 真空干燥 1 天, 温度为 37°C, 压力为 0.001325MPa~0MPa, 即得到本发明的组织、 器官修复用多孔支架。 7. Dry under vacuum for 1 day, the temperature is 37 ° C, and the pressure is 0.001325MPa ~ 0MPa, then the porous scaffold for tissue and organ repair of the present invention is obtained.
如图 1和图 2所示的聚 3 -羟基丁酸酯支架材料, 可见在该支架 材料中既有大孔, 又有小孔, 并且大孔-大孔、 大孔-小孔、 小孔-小 孔之间相互连通, 适合各种大小细胞的生长。 图 3为由该聚 3 -羟基 丁酸酯支架材料的外观图, 其可根据实际需要被制作成各种不同的 外观形状。 实施例 2 As shown in the poly 3-hydroxybutyrate stent material shown in Figures 1 and 2, it can be seen that there are both large holes and small holes in the stent material, and there are large holes-large holes, large holes-small holes, and small holes. -The pores communicate with each other, suitable for the growth of cells of various sizes. FIG. 3 is an external view of the poly 3-hydroxybutyrate stent material, which can be made into various external shapes according to actual needs. Example 2
1、 在 60°C下,于烧杯中用 1.5 克的乳酸和羟基乙酸共聚物 (PLGA), 10ml 1,4 -二氧六环配制成 15% (质量比体积) PLGA溶液。 1. Prepare a 15% (mass to volume) PLGA solution in a beaker with 1.5 g of lactic acid and glycolic acid copolymer (PLGA) and 10 ml of 1,4-dioxane at 60 ° C.
2、 加入 22.5g KC1, 其中 C1直径在 100微米〜 400微米之间 。 2. Add 22.5g KC1, where C1 is between 100 microns and 400 microns in diameter.
3、 搅拌下倒入预置温度为 0°C的模具中骤冷。 3. Pour into a mold with a preset temperature of 0 ° C while stirring and quench it.
4、 冷冻 20分钟后, 开模取得所需形状的样品。 4. After freezing for 20 minutes, open the mold to obtain a sample of the desired shape.
5、 于 0°C、 于 0.001325MPa~0MPa下冷冻千燥 4天。 5. Freeze and dry at 0 ° C for 4 days at 0.001325MPa ~ 0MPa.
6、 取出样品, 将其浸入去离子水, 每 8小时换一次水, 浸泡 3 天。 6. Take out the sample, immerse it in deionized water, change the water every 8 hours, and soak for 3 days.
7、 真空干燥 1 天, 温度为 37°C , 压力为 0.001325MFa〜0MFa, 即得到本发明的组织、 器官修复用多孔支架。
实施例 3 7. Dry under vacuum for 1 day, the temperature is 37 ° C, and the pressure is 0.001325MFa ~ 0MFa, then the porous scaffold for tissue and organ repair of the present invention is obtained. Example 3
1、 在 55°C下, 于烧杯中用 1.5克的 3-羟基丁酸酯与 3 -羟基己 酸酯的共聚物(PHB-HH), 10ml 1 ,4-二氧六环—水混合物 (1,4-二氧 六环、 水体积比为 87:13) 配制成 15% (质量比体积) 配制 FHB - HH 溶液。 1. At 55 ° C, use 1.5 g of copolymer of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHB-HH) in a beaker, 10 ml of 1,4-dioxane-water mixture ( 1,4-dioxane, water volume ratio 87:13) Formulated to 15% (mass specific volume) Formulated FHB-HH solution.
2、 力口入 22.5g KC1, 其中 KC1直径在 100徵米〜 400微米之间 。 2. Insert 22.5g KC1 into the mouth, where the diameter of KC1 is between 100 to 400 microns.
3、 搅拌下倒入用液氮 (约 -170°C) 冷却的模具中骤冷。 3. Pour into a mold cooled with liquid nitrogen (approximately -170 ° C) with stirring to quench.
4、 冷冻 20分钟后, 开模取得所需形状的样品。 4. After freezing for 20 minutes, open the mold to obtain a sample of the desired shape.
5、 于 0°C、 0.001325MPa~0MPa下冷冻干燥 4天。 5. Freeze-dry at 0 ° C, 0.001325MPa ~ 0MPa for 4 days.
6、 取出样品, 将其浸入去离子水, 每 8小时换一次水, 浸泡 3 天。 6. Take out the sample, immerse it in deionized water, change the water every 8 hours, and soak for 3 days.
7、 真空干燥 1 天, 温度为 37°C, 压力为 0.001325MPa~0MPa, 即得到本发明的组织、 器官修复用多孔支架。 7. Dry under vacuum for 1 day, the temperature is 37 ° C, and the pressure is 0.001325MPa ~ 0MPa, then the porous scaffold for tissue and organ repair of the present invention is obtained.
图 4为由该实施例的 PHB-HH支架材料为基础得到的耳形支架的 外观图, 可见由于采用了本发明的相分离粒子滤出法使得到外观形状 复杂的支架成为可能。 实施例 4 FIG. 4 is an external view of an ear-shaped stent obtained based on the PHB-HH stent material of this embodiment. It can be seen that the use of the phase separation particle filtration method of the present invention makes it possible to obtain a stent with a complicated appearance. Example 4
1、在 60°C下, 于烧杯中选用 1.5克的聚乳酸 (PLA), 10ml 1,4- 二氧六环配制 15%成 (质量比体积) PLA溶液。 1. At 60 ° C, select 1.5 grams of polylactic acid (PLA) and 10 ml of 1,4-dioxane in a beaker to prepare a 15% (mass to volume) PLA solution.
2、加入 22.5g NaCl, 其中 NaCl直径在 100微米〜 400微米之间 。 2. Add 22.5g NaCl, where the diameter of NaCl is between 100 microns and 400 microns.
3、 搅拌下倒入预置温度为- 15°C的模具中骤冷。 3. Pour into a mold with a preset temperature of -15 ° C while stirring and quench it.
4、 冷冻 20分钟后, 开模取得所需形状的样品。 4. After freezing for 20 minutes, open the mold to obtain a sample of the desired shape.
5、 于 -15°C、 于 0.001325MPa~0MPa下冷冻千燥 4天。 5. Freeze and dry for 4 days at -15 ° C and 0.001325MPa ~ 0MPa.
6、 取出样品, 将其浸入去离子水, 每 8小时换一次水, 浸泡 3天。 6. Take out the sample, immerse it in deionized water, change the water every 8 hours, and soak for 3 days.
7、 真空千燥 1 天, 溫度为 37°C , 压力为 0.001325MPa~0MFa, 即得到本发明的组织、 器官修复用多孔支架。
实施例 5 7. Vacuum dry for 1 day, the temperature is 37 ° C, and the pressure is 0.001325MPa ~ 0MFa, then the porous scaffold for tissue and organ repair of the present invention is obtained. Example 5
采用实施例 1制得的聚羟基丁酸酯 (PHB) 支架材料, 在动物体 内抅建組织工程化人工软骨, 整个实验由军事医学科学院基础医学 研究所与清华大学合作完成。 The polyhydroxybutyrate (PHB) scaffold material prepared in Example 1 was used to construct tissue-engineered artificial cartilage in the animal. The entire experiment was completed by the Institute of Basic Medicine of the Academy of Military Medical Sciences and Tsinghua University.
取新西兰幼兔关节软骨, 分离培养软骨细胞, 并将一定数量的 软骨细胞接种到实施例 1 制备的 PHB 支架材料上, 形成细胞——支 架复合体, 随后将该复合体移植到新西兰兔背部皮下, 术后第 8 周 和第 12周取材, 经組织学、 組织化学等染色观察, 皆可见复合体内 有软骨組织形成, 并且该 I¾B 支架材料生物相容性好, 可以作为软 骨细胞的人工细胞外基质材料。该 PHB多孔支架材料的溶血程度 <5%, 满足生物材料溶血栎准, 其种植实验显示材料无明显炎症及排斥反 应, 无组织坏死和纤维包囊现象, 表明 PHB 材料具有良好的组织相 容性。 工业应用性 The articular cartilage of New Zealand young rabbits was taken, chondrocytes were isolated and cultured, and a certain number of chondrocytes were seeded on the PHB scaffold material prepared in Example 1 to form a cell-scaffold complex, which was then transplanted under the skin of the New Zealand rabbit's back At 8 and 12 weeks after surgery, samples were taken for histology and histochemical staining, and cartilage tissue formation was found in the complex. The I¾B scaffold material was biocompatible and could be used as an artificial extracellular for chondrocytes. Matrix material. The PHB porous scaffold material has a degree of hemolysis of <5%, which meets the requirements of hemolytic oak of biomaterials. The planting experiments showed that the material has no obvious inflammation and rejection, no tissue necrosis and fibrous encapsulation. . Industrial applicability
本发明的组织和器官修复用多孔支架的制备方法, 工艺简单、 操作容易, 可根据实际组织和器官修复对多孔支架材料的要求, 得 到具有一定的降解速度、 孔径均匀可调的多孔支架, 并可直接制备 结抅复杂的三维立体结构的支架材料, 有效地解决了公知技术中存 在的粒子沉降和闭孔的问题。 由本发明方法制得的多孔支架具有良 好的组织相容性, 将其种植于活体皮下, 无明显炎症及排斥反应, 无组织坏死和纤維包囊现象, 可在有免疫力的动物体内抅建组织工 程骨, 具有很好的工业应用前景。
The method for preparing a porous scaffold for tissue and organ repair according to the present invention has simple process and easy operation, and can obtain a porous scaffold with a certain degradation rate and uniformly adjustable pore diameter according to the requirements of the actual tissue and organ repair for the porous scaffold material, and The scaffold material with complex three-dimensional structure can be directly prepared, which effectively solves the problems of particle sedimentation and closed pores existing in the known technology. The porous scaffold prepared by the method of the invention has good histocompatibility. It is implanted under the skin of a living body, without obvious inflammation and rejection, without tissue necrosis and fibrous encapsulation, and can be used to build tissues in immune animals. The engineering bone has a good industrial application prospect.